| __timestamp | Iovance Biotherapeutics, Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2704597 | 396000000 |
| Thursday, January 1, 2015 | 15470000 | 364000000 |
| Friday, January 1, 2016 | 28037000 | 376000000 |
| Sunday, January 1, 2017 | 71615000 | 382000000 |
| Monday, January 1, 2018 | 99828000 | 432000000 |
| Tuesday, January 1, 2019 | 166023000 | 457000000 |
| Wednesday, January 1, 2020 | 201727000 | 463000000 |
| Friday, January 1, 2021 | 259039000 | 508000000 |
| Saturday, January 1, 2022 | 294781000 | 539000000 |
| Sunday, January 1, 2023 | 344077000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
Unlocking the unknown
In the dynamic world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Zoetis Inc. and Iovance Biotherapeutics, Inc. have showcased contrasting R&D investment strategies. From 2014 to 2023, Zoetis consistently outpaced Iovance, with R&D spending peaking at approximately 614 million USD in 2023, a 55% increase from 2014. Meanwhile, Iovance's R&D expenses surged by an impressive 12,600%, reaching around 344 million USD in 2023. This stark contrast highlights Zoetis's steady commitment to innovation, while Iovance's exponential growth reflects its aggressive push in the biotech arena. As these companies continue to evolve, their R&D investments will be pivotal in shaping their future breakthroughs and market positions.
Research and Development Expenses Breakdown: AbbVie Inc. vs Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: United Therapeutics Corporation vs Iovance Biotherapeutics, Inc.
Intra-Cellular Therapies, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Corcept Therapeutics Incorporated vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Verona Pharma plc vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MorphoSys AG vs Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or Galapagos NV: Who Invests More in Innovation?